A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout

NCT00741442 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

3

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperuricemia

Interventions

DRUG: RDEA806
DRUG: Placebo

Sponsor

Ardea Biosciences, Inc.